InMed Pharmaceuticals (INM) Other Non Operating Income (2019 - 2026)
InMed Pharmaceuticals (INM) posted quarterly Other Non Operating Income of -$23168.0 for Q1 2026, down 4.53% year-over-year from -$24266.1 in Q1 2025, and down 227.75% quarter-over-quarter from $18136.0 in Q4 2025.
InMed Pharmaceuticals (INM) Other Non Operating Income (2019 - 2026) Analysis & Trends
InMed Pharmaceuticals' Other Non Operating Income history runs 8 years deep, the most recent figure standing at -$23168.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 4.53% year-over-year to -$23168.0; the TTM figure through Mar 2026 stood at -$39889.0 (up 47.38% YoY), while the FY2025 annual figure was -$28471.0, up 54.02% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$23168.0, down from $18136.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $59896.0 in Q4 2023, with the low at -$96791.0 in Q3 2022.
- The 5-year median for Other Non Operating Income is -$22165.0 (2025), against an average of -$13943.5.
- The sharpest annual moves came in 2022 and 2024: Other Non Operating Income surged 573.0% in 2022, then plunged 1662.02% in 2024.
- InMed Pharmaceuticals' Other Non Operating Income stood at $20237.0 in 2022, then jumped by 195.97% to $59896.0 in 2023, then slumped by 179.73% to -$47753.0 in 2024, then jumped by 137.98% to $18136.0 in 2025, then slumped by 227.75% to -$23168.0 in 2026.
- Business Quant data shows INM's Other Non Operating Income at -$23168.0 in Q1 2026, $18136.0 in Q4 2025, and -$56994.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.75 Bn | 42.79 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.22 Bn | 39.57 Bn | 2.15 Bn |
| 3 | Zoetis | 31.40 Bn | 29.72 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.61 Bn | 15.22 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.96 Bn | 11.43 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.08 Bn | 9.91 Bn | - |
| 10 | InMed Pharmaceuticals | 6.68 Mn | 1.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23,168.00 |
| Dec 31, 2025 | 18,136.00 |
| Sep 30, 2025 | -56,994.00 |
| Jun 30, 2025 | 22,137.00 |
| Mar 31, 2025 | -22,165.00 |
| Dec 31, 2024 | -47,753.00 |
| Sep 30, 2024 | 19,310.00 |
| Jun 30, 2024 | -25,204.00 |
| Mar 31, 2024 | -48,156.00 |
| Dec 31, 2023 | 59,896.00 |
| Sep 30, 2023 | -48,457.00 |
| Jun 30, 2023 | 31,112.00 |
| Mar 31, 2023 | -2,733.00 |
| Dec 31, 2022 | 20,237.00 |
| Sep 30, 2022 | -96,791.00 |
| Jun 30, 2022 | -69,442.00 |
| Mar 31, 2022 | 32,996.00 |
| Dec 31, 2021 | 3,007.00 |
| Sep 30, 2021 | -84,112.00 |
| Jun 30, 2021 | -187,815.00 |